These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 28463851)
1. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes. Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851 [TBL] [Abstract][Full Text] [Related]
2. [Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy]. Hattenbach LO; Kuhli-Hattenbach C; Springer C; Callizo J; Hoerauf H Ophthalmologe; 2016 Jul; 113(7):581-8. PubMed ID: 26879555 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes. Chatziralli I; Dimitriou E; Theodossiadis G; Chatzirallis A; Kazantzis D; Theodossiadis P Ophthalmologica; 2019; 242(1):16-21. PubMed ID: 30889589 [TBL] [Abstract][Full Text] [Related]
4. RESIDUAL INTRARETINAL EDEMA AFTER 25-GAUGE VITRECTOMY AND MACULAR PUCKER REMOVAL: Is Intraoperative Sustained-release Dexamethasone a Real Treatment Option? Guidi G; Casini G; Ripandelli G; Piaggi P; Dalle Lucche F; Sartini M; Loiudice P; Nasini F; Stirpe M; Lazzeri S Retina; 2018 May; 38(5):993-999. PubMed ID: 28376039 [TBL] [Abstract][Full Text] [Related]
5. Use of a dexamethasone implant to treat macular edema following pars plana vitrectomy and removal of the primary epiretinal membrane. Boz AAE; Çelik E; Atum M; Çakır B; Aksoy NÖ; Özmen S; Doğan E; Yuvacı İ Int Ophthalmol; 2024 Aug; 44(1):340. PubMed ID: 39102035 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
7. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema. Bansal P; Agarwal A; Gupta V; Singh R; Gupta A Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema. Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U; Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J Retina; 2013; 33(7):1435-40. PubMed ID: 23514796 [TBL] [Abstract][Full Text] [Related]
16. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion. Lee KH; Kang EC; Koh HJ Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038 [TBL] [Abstract][Full Text] [Related]